Circulating polymorphonuclear granulocytes (PMNs), vascular endothelial cells (ECs), and perivascular mast cells (MCs) play a concerted action in inflammation. Circulating PMNs are short lived cells that are readily mobilized by exposure to a variety of stimuli. Formyl-methionyl peptides (fMLPs) are among the best known inflammatory stimuli. They are released from bacteria at the site of infection and bind to specific receptors on the surface of circulating PMNs, initiating the chemotactic response. The chemotactic response entails a series of sequential events, including the adhesion of the circulating PMNs to the endothelium of neighboring capillaries, the migration toward the infected tissues after crossing the endothelium, and finally the engulfment of bacteria. Concomitantly with the engulfment of bacteria, PMNs undergo the respiratory burst, which consists of the marked activation of oxidative metabolism, resulting in the generation of superoxide anion (O 2 ⅐ Ϫ ), and to degranulation, which consists in the release of proteolytic enzymes from the cytoplasmic granules, the two processes leading to killing and digestion of engulfed bacteria (1) . However, under adverse circumstances, O 2 ⅐ Ϫ and derived metabolites may be released by PMNs in an uncontrolled manner, exerting cytotoxic effects on the neighboring cells and tissues, as in the signs and symptoms of acute and chronic inflammation (1) .
A concerted action between PMNs and ECs initiates and sustains the inflammatory process. During inflammation, PMNs tether and roll on the EC surface. The cells then arrest, spread, and finally migrate between ECs to reach underlying tissues. The process of adhesion of PMNs to ECs and transendothelial migration is regulated by the expression on EC surface of adhesion molecules, ICAM-1 (CD54) among them. ICAM-1 enables the ␤-2 integrin (CD11b) in PMNs to firmly bind PMNs to the EC surface (2) . Thus, ECs express cell surface-molecules that orchestrate the trafficking of circulating blood cells, and the uncontrolled adhesion of PMNs to ECs contributes to inflammatory disorders (2) .
Tissue MCs are the third cell lineage relevant to inflammation, capable of cross-talking with the activated PMNs. The mediator of the interaction between PMNs and MCs could be identified with O 2 ⅐ Ϫ and the subsequent free radical cascade. Previous experiments have shown that free radicals are powerful releasers of MC histamine. Rat peritoneal MCs undergo extensive degranulation and histamine release in the presence of xanthine/xanthine oxidase, a source of O 2 ⅐ Ϫ (3). fMLP-primed PMN evokes histamine release from MCs (4), and reactive oxygen species (ROS) are associated with the release of histamine in a variety of pathophysiological events, such as hyperoxic exposure, antracycline cardiomyopathy, and oleic acid induced pulmonary injury (5) .
Therefore, we hypothesize that the three cell lines, PMNs, ECs, and MCs, may initiate and sustain the inflammatory response through the generation of O 2 ⅐ Ϫ by PMNs primed by inflammatory stimuli, which in turn evoke the overexpression of adhesion molecules from ECs and the release of histamine by MCs. Within this frame, the recently acquired gasotransmitter, carbon monoxide (CO), modulates the inflammatory response by interacting with ECs and with MCs. The anti-inflammatory effects of CO have been extensively reviewed. CO was found to inhibit the production of proinflammatory cytokines; an inflammatory syndrome develops in HO-1-deficient humans and in HO-1 null mice and CO blocks the proliferation of cultured CD4ϩ T cells and exerts protective effects on experimental models of inflammation, both in vivo and in vitro (6, 7) .
An important mechanism underlying the CO-mediated anti-inflammatory effect is the down-regulated expression of adhesion molecules by ECs. In rat mesenteric microvessels, venular leukocyte adhesion was elicited by oxidants such as hydrogen peroxide or hemorrhagic shock followed by reperfusion. Treatment with hemin, an inducer of HO-1, produces the expected increase in the plasma levels of bilirubin, in parallel with the consensual decrease of the venular leukocyte adhesion (8) . Other sets of experiments showed that when HO-1 expression was first up-regulated by local stress conditioning, the overexpression of ICAM-1 induced by subsequent injury was significantly decreased (9) .
It is known that HO-1 is the rate-limiting enzyme in the catabolism of heme to free iron, CO, and biliverdin, immediately converted to bilirubin by biliverdin reductase (10) . Therefore, the protection afforded by HO-1 overexpression on vascular inflammation could be related to bilirubin, ferritin from free iron, or CO. To pinpoint the role of CO in curbing vascular inflammation, CO-releasing molecules (CO-RMs) are adequate tools to asses the role of CO in the cytoprotection and inflammation-limiting effects of HO-1 overexpression (11) . The pharmacological and potential therapeutic effects of CO-RMs have been extensively reviewed (12) (13) (14) .
In the present study, we examined the effect of a water soluble CO-RM [tricarbonylchloro-glycinate-ruthenium (II); CORM-3] on an experimental model of vascular inflammation. The model consists of coincubating fMLP-primed human PMNs with rat ECs or with rat MCs. The effects of CORM-3 were evaluated by measuring the generation of O 2 ⅐ Ϫ and the expression of CD11b in fMLP-primed PMNs; the expression of ICAM-1 and CD203c in ECs and MCs, respectively; and the release of histamine from MCs.
MATERIALS AND METHODS

Materials
Tricarbonylchloro(glycinate) ruthenium (II) [Ru(CO)3Cl-(glycinate)] or CORM-3 and its inactive counterpart (iCORM-3) were synthesized and prepared as described previously (15, 16) . SOD, ferricytochrome C, and trypsin were from Boehringer (Mannheim, Germany). Amphotericin, penicillin G, histamine HCl, cytochalasin B, M199 medium, type I collagenase, 1 H-(1,2,4)-oxadiazolo-(4,2-␣)-quinoxalin-1-one (ODQ), and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were from Sigma Chemical (St. Louis, MO, USA). Newborn calf serum was from Gibco-BRL (Paisley, Scotland), and Ficoll-Paque was from Pharmacia Biotec (Uppsala, Sweden). Anti-CD11b phycoerythrin PE-conjugated, anti-CD54 (ICAM-1) PE-conjugated, and antiCD203c PE-conjugated antibodies were from Coulter (Hialeah, FL, USA). Fluo-4 AM and Fura-Red were from Invitrogen S.R.L. (Milan, Italy).
Isolation of human neutrophils
Approximately 20 ml of venous blood anticoagulated with sodium heparin (500 IU/ml, Hepoxoclar Lab, Milan, Italy) was collected from 8 healthy volunteers who did not suffer from inflammatory or infectious diseases and had not taken any drug in the previous 4 wk. The subjects gave explicit informed consent to their enrollment in this study. Males were chosen to avoid possible influences due to endogenous hormones on the experimental findings. The experimental protocol was designed in compliance with the guidelines of the Ethical Committee of the University of Florence, Italy. Neutrophils were obtained by dextran sedimentation followed by Ficoll-Paque density gradient centrifugation and hypotonic lysis for removal of residual erythrocytes (17 
Isolation and culture of rat coronary ECs
Rat coronary ECs were isolated as described previously (18) from hearts of 12-to 15-wk-old male Wistar rats. For all experiments, cells were used at the first passage in culture.
Briefly, hearts were mounted in a Langendorff apparatus and washed and digested with 0.1% type I collagenase. After 20 min, ventricles were cut, and cells were dispersed and filtered through a 200 m cell strain. After centrifugation (25 g for 3 min), the supernatant was maintained under stirring for 30 min at 37°C in the presence of 10 mg/50 ml trypsin. Cells, obtained by centrifugation (250 g for 10 min), were resuspended in 15 ml of culture medium (see below) and plated in 75 cm 2 flasks. After 4 h, cells were washed twice and grown in 10 ml culture medium until confluence (5-6 days). Cells were used for all experiments at the first passage. M199 medium, containing 10% fetal calf serum, 10% newborn calf serum, 250 IU/ml penicillin G, 0.625 g/ml amphotericin, and 250 g/ml streptomycin, was used as culture medium. Extensive cytological characterization of isolated cells demonstrated a 95% positive cell for markers of endothelial origin (vimentin, Von Willebrand factor and DiI-ac-LDL uptake).
O 2 ⅐ Ϫ production was evaluated by SOD inhibitable reduction of ferricytochrome C (19) in resting conditions and after stimulation with 10 Ϫ8 M fMLP. Briefly, 50,000 human polymorphonucleated neutrophils were incubated in basal conditions or in the presence of CORM-3 at different concentrations for 2 h with or without fMLP stimulation.
Isolation of rat serosal MCs
MCs from the abdominal and thoracic cavities were isolated according to the techinique previously described (20) . Male Wistar albino rats (200 -400 g) were anesthetized with ether and killed by decapitation. MCs were isolated from pleural and peritoneal washings by gradient centrifugation in Ficoll (MW 400,000) and suspended in a medium containing 145 mM NaCl, 2.4 mM KCl, 0.9 mM CaCl 2 , 0.1% glucose, and 1% human serum albumin adjusted to pH 7.4 with 10% (v/v) Sörensen phosphate buffer (1/15 M).
Cell viability assay
The possible cytotoxic effect of different concentrations of CORM-3 was evaluated by an MTT test. The MTT assay is a colorimetric method in which the dye intensity is proportional to the number of viable cells. Cells were seeded into 96-well microtiter plates and treated with increasing concentrations of test substance. After incubation, MTT was added to the cell culture medium, and the formazan crystals were dissolved in 200 l of DMSO. MTT reduction was quantified by measuring the light absorbance with a multilabel plate counter (Wallace Victor2, Perkin Elmer, Monza, Italy) at 570 nm (21) . Experiments were performed in triplicate, and data are expressed as the percentage of MTT reduction compared to control cells.
Cytofluorimetric analysis
The neutrophil suspensions were labeled with anti-CD11b phycoerythrin PE-conjugated antibodies at saturating concentrations as provided by the manufacturer. Surface expression of CD11b is considered a reliable marker to identify activated neutrophils. EC suspensions were labeled with anti-CD54 (ICAM-1) PE-conjugated antibodies and with the appropriate isotype immunoglobulin G (phycoerythrin or FITC) as control. Rat MCs suspension were labeled with anti-CD203c PE-conjugated antibodies. The fluorescent antibodies were incubated with the cell suspensions for 20 min and analyzed with a flow cytometer (EPICS XL, Coulter). The neutrophil-, EC-, and MC-related events were sorted using appropriate electronic gates. The presence or absence of the fluorescent signal from PE (emission peak at 575 nm) was used to characterize activated and nonactivated neutrophils, respectively (17, 22) .
Aliquots of the neutrophil suspensions, each containing 10 5 cells, were treated as described above. Cells were then treated with cytochalasin B (5 g/ml) before exposure to fMLP to inhibit cell motility and spontaneous degranulation and to potentiate O 2 ⅐ Ϫ production (23) . O 2 ⅐ Ϫ was monitored by the method reported by Babior et al. (24) , which allows a continuous spectrophotometrical measurement of the SOD-induced inhibition of cytochrome c reduction. None of the drugs used in the experiments affected O 2 ⅐ Ϫ production in a cell-free xanthine-xanthine oxidase system.
Intracellular Ca 2؉ assay
Intracellular calcium was evaluated using a flow cytometer (EPICS XL Coulter). Neutrophils were suspended in 1 ml of buffer enriched with Ca 2ϩ and Mg 2ϩ (THC buffer) and incubated for 30 min at 37°C with 5 l of Fluo-4 AM (which increases fluorescence when it binds intracellular Ca 2ϩ , final concentration of 1.7 M) and with 10 l of Fura-Red (which decreases fluorescence when it binds intracellular Ca 2ϩ , final concentration 5.3 M). The ratio between the Fluo-4 AM-and Fura-Red-induced fluorescence allows the highest sensitivity in the evaluation of Ca 2ϩ transient. The ratio of Fluo-4AM to Fura-Red was plotted vs. time, and the exact calcium concentration was determined through a calibration curve.
Histamine release experiments
The 50 l MC suspension (number of cells 5ϫ10 4 ) was added to test tubes containing various concentrations of CORM-3, iCORM, or SOD in a final volume of 2 ml. The samples were preincubated at 37°C in a metabolic shaker for 15 min; the gas phase was air. After 15 min, 50 l PMN suspension (10 6 cells) was added directly to the test tubes and stimulated with chemotactic peptide fMLP (10 Ϫ7 M). The same procedure was used for control cells, except that they were incubated for 15 min in a drug-free medium. Incubation at 37°C was allowed to proceed for 10 min after the addition fMLP. The release was stopped by chilling the tubes in an ice-water bath. Cells were then separated from the medium by centrifugation (400 g for 5 min), and histamine was fluorimetrically assessed in the supernatants and in the pellets using the method of Shore et al. (25) as modified by Kremzner and Wilson (26) . Histamine release was always expressed as a percentage of the total histamine; spontaneous histamine release ranged between 1 and 5% and was subtracted from all values.
Statistical analysis
Data are presented as the mean Ϯ se, and the significance was evaluated with ANOVA test followed by Bonferroni's t test.
RESULTS
Evaluation of CORM-3 on cell viability
The possible cytotoxic effect of three different concentrations of CORM-3 (100 nM-10 M) was evaluated by means of the MTT test in rat MCs, human neutrophils, and rat coronary ECs. As shown in Fig. 1 
Effects of CORM-3 on the activation of human PMNs induced by fMLP
fMLP is a synthetic chemotatic peptide, alike to these of bacterial origin, able to induce O 2 ⅐ Ϫ production and enzyme release from both azurophyl and specific granules in cytochalasin B-treated human PMNs (26, 4) . The fMLP-induced respiratory burst in human PMNs is inhibited by histamine (27) , by adrenergic agonists and prostaglandins of the E series (28) , and by a bioflavonoid, silymarin (5) . In the present experiments, we confirmed our previous data (5, 29) showing that human PMNs express a basal production of O 2 ⅐ Ϫ , which can be increased many fold by fMLP at a concentration of 10 Ϫ7 M, consistent with the average concentrations previously evaluated (10 Ϫ9 to 10 Ϫ6 M) (5, 27, 29) . Under these conditions, CORM-3 decreased O 2 ⅐ Ϫ production in a concentration-dependent fashion. Consistently, SOD also nullified the fMLP-driven increase in the generation of O 2 ⅐ Ϫ . iCORM-3, which does not release CO and serves as internal control, was totally ineffective (Fig. 2) .
The fMLP-induced activation of human PMNs was extended to the evaluation of the expression of CD11b antigen on the cell surface, the subunit that creates the CD11b/CD18 integrin, prerequisite for the adherence of PMNs to the CD54/ICAM-1 expressed by ECs. In fact, CD11b was expressed in resting PMNs and increased many fold in the presence of fLMP (10 Ϫ7 M). Under these circumstances, CORM-3 significantly reduced the fMLP-induced rise of CD11b in a concentration-dependent fashion, while iCORM-3 and SOD were inactive (Fig. 3) .
It is notable that the intracellular Ca 2ϩ flow in human PMNs was significantly increased by fMLP and that CORM-3 significantly reduced in a concentrationdependent way the increase in calcium content. This effect was reversed by preincubating the cells with ODQ, indicating that CORM-3 exerts its anti-inflammatory action through the modulation of guanylyl cyclase ( Table 1 and Fig. 4) .
Effects of CORM-3 on the activation of ECs by fMLP-primed human PMNs
Rat coronary ECs express the intercellular adhesion molecule-1 (CD54/ICAM-1), a member of the immunoglobulin cell surface receptors, which combines with the CD11b on the cell surface of PMNs to initiate tethering and rolling of PMNs on endothelial lining. Coincubation of quiescent human PMNs with ECs resulted in an increase over the basal values of CD54 expression. Coincubation of fMLP-primed PMNs with ECs resulted in a further increase in the expression of CD54 by ECs, which reached the maximum at fMLP concentration of 10 Ϫ7 M (Fig. 5) . It is notable that fMLP did not induce any overexpression of CD54 by ECs at any given concentrations (data not shown). The maximal expression of CD54 from ECs induced by fMLP primed human PMNs was used to evaluate the effect of CORM-3. Under these conditions, CORM-3 concentration dependently decreased and nullified the CD54 expression by ECs induced by fMLP-primed human PMNs. Consistently, SOD dose dependently reverted the overexpression of CD54, while iCORM-3 was ineffective (Fig. 6) .
Effects of CORM-3 on the activation of rat MCs by fMLP-primed human PMNs
Unstimulated rat MCs spontaneously release a basal amount of histamine. Adding to rat MC quiescent human PMNs significantly increased the release of histamine (29) . Adding fMLP to the coincubation of rat MCs and human PMNs produced a maximal increase in the release of histamine, which was used to evaluate the effect of CORM-3. Under these conditions, CORM-3 concentration dependently decreased and nullified the release of histamine from MCs induced by the fMLPprimed human PMNs. It is worth mentioning that fMLP induces a concentration-dependent release of ␤-glucuronidase from human PMNs, while it was ineffective on ␤-glucuronidase and histamine release in rat MCs (29) . The inhibitory effect of CORM-3 was dose dependently mimicked by SOD, while iCORM-3 was ineffective (Fig.  7) . The release of histamine was reinstated by the guanyl cyclase blocker ODQ (10 Ϫ5 M; data not shown). In separate experiments, we have evaluated the O 2 ⅐ Ϫ production by fMLP-primed human PMNs and found that it was parallel with the release of histamine from MCs in a concentration-dependent fashion (Fig. 8) .
The expression of the CD203c antigen is restricted to basophils and MCs, and it is known to undergo a rapid up-regulation after allergen challenge. Beside the release of histamine, in the present experiments we used the evaluation of the CD203c expression as an activation marker of MCs. A minute amount of CD203c was expressed by resting MCs. Addition of unstimulated PMNs produced a significant increase in the CD203c expression that was raised to the maximum by adding fMLP-primed PMNs. Under these conditions, CORM-3 concentration dependently decreased and nullified the increased expression of CD203c from MCs, induced by fMLP-primed human PMNs; the inhibition was mimicked by SOD and left unchanged by iCORM (Fig. 9) .
DISCUSSION
The present experiments show that the chemotactic peptide fMLP primes PMNs to generate O 2 ⅐ Ϫ and overexpress CD11b, both events being central to the inflammatory process by initiating phagocytosis and the adhesion of PMNs to ECs (1); the water-soluble CORM-3 nullifies these events. The experiments also show that fMLP-primed PMNs increase the CD54 expression by coincubated ECs and the expression of CD203c and the release of histamine by coincubated MCs; once again, CORM-3 abolishes these events. Thus, CORM-3 exerts a powerful anti-inflammatory action by down-regulating the oxidative burst in PMNs, the overexpression of adhesion molecules in PMNs and in ECs, the release of histamine, and the overexpression of an activation marker by MCs. These inhibitory actions are attributable directly to CO, since the CO-deprived negative control (iCORM-3) does not reproduce these effects. The dismutation of O 2 ⅐ Ϫ by SOD down-regulates the inflammatory response, showing the crucial role of O 2 ⅐ Ϫ in the initial events of inflammation. Conceivably, the three cell lines (PMNs, ECs, and MCs) may initiate and sustain the inflammatory response through the overproduction of O 2 ⅐ Ϫ by fMLP-primed PMNs, which in turn evokes the overexpression of CD54 from ECs, and the release of histamine from MCs. ROS generated by the loss of shear stress are a signal for initiating the activation of mouse pulmonary microvascular ECs (30) ; under oxidative conditions, O 2 ⅐ Ϫ reacts with NO to generate peroxynitrite (ONOO Ϫ ), which promotes the induction of PMNs adhesion to ECs and causes endothelial dysfunction (31) .
Therefore, the inhibitory effect of CORM-3 could be related to CO acting on the generation of O 2 ⅐ Ϫ from fMLP-primed PMNs. This is supported by data obtained
Ϫ production is observed after incubation with CORM-2 (tricarbonyldichlororuthenium dimer), a lipid-soluble CO-RM (32, 33) .
Our data reveal a significant role for exogenously applied CO on the expression of adhesion molecules by ECs and on the release of histamine and the expression of activation markers by MCs. This is in agreement with evidence showing a similar contribution by the activation of the endogenous HO/CO system, although it remains to be fully established which one among the end products of HO-1 activity is involved in the observed effects. For instance, in the experiments reported by Hayashi et al. (8) , the hydrogen peroxideinduced leukocyte adhesion to rat mesenteric ECs was decreased in HO-1 induced animals, and the decrease was mimicked by bilirubin, by biliverdin, but not by exogenous CO gas. The expression of P and E selectin in different regional vascular beds of the rat was increased in lipopolysaccharide-treated animals, and the overexpression of selectins was decreased in a similar fashion by pretreatment with hemin, bilirubin, biliverdin, but not by exogenous CO gas (34) . CO is endogenously produced in the upper respiratory tract, and increased compensatory levels have been reported in allergic inflammation of the airways (35) .
Other evidence indicates that HO-1-derived CO modulates in turn the expression of adhesion molecules by ECs. In fact, HO-1 expression is upregulated after hemorrhagic shock, and the HO-product CO plays a central role in the preservation of tissue microvasculature (36) . The levels of mRNA for ICAM-1 were increased many fold in rat kidney allografts under air and significantly reduced by inhaling CO at low concentrations, which abrogates the vascular inflammation associated with chronic allograft nephropathy (37) . Therefore, the question whether CO is the main actor in curbing the generation of adhesion molecules in response to inflammatory stimuli is still pending. Our present data, by showing that CO released by CORM-3 unequivocally blunts the generation of CD54 by ECs coincubated with fMLP-primed PMNs, are in contrast with the results of experiments showing that CO does not reduce the expression of adhesion molecules in ECs after inflammatory stimuli. It is conceivable that the difference in the results could be due to the different modalities of administration. In the experiments in which CO was administered as a gas, the negative results might depend on the uncertain titration, in comparison with the more precise concentrations which can be reached by the CO-RMs. In fact, one of the advantages of using CO-RM is the possibility to prepare and deliver not only precise concentrations of CO but also channel the gas more effectively to cells and tissues (38) . Our present experiments are supported by data showing that in a model of acute inflammation, pretreatment with a HO substrate (hemin), or a CO donor (dimanganese-decacarbonyl) or biliverdin reduced neutrophil rolling, adhesion, and migration in the mesenteric microcirculation of mice (39) .
Moreover, in phenotype of guinea pig MCs, hemin exposure decreases significantly the antigen-induced release of histamine (40) , which is paralleled by the increase in cGMP levels and the decrease in intracellular Ca 2ϩ . Thus, it appears evident that, in guinea pig MCs, the induction of HO-1 abrogates the immunological response by means of CO acting on guanylatecyclase to increase cGMP levels and to decrease Ca 2ϩ levels, essential steps in granule exocytosis (40) . In human basophils challenged with anti-IgE, the direct exposure to CO decreased the immunological response in equal fashion as the induction of HO-1 (41, 42) . It is of interest that CORM-2 decreases the release of histamine and the expression of the activation marker CD2O3c in antigen-challenged guinea pig MCs (43) .
As for the inhibitory effect of CO on the oxidative burst of PMNs and on the activation of ECs and MCs, we here provide direct evidence that addition of CORM-3 determinates the diminution of the Ca 2ϩ flow in fMLP-primed PMNs, an effect reverted by a blocker of guanylate cyclase (ODQ), but other mechanisms may be involved in the pleiotropic action of CO. Carbon monoxide has been reported to activate Ca 2ϩ -sensitive K ϩ channels and to inhibit Ca 2ϩ influx through the L-type Ca 2ϩ channels (44, 45) . Other evidence suggests that the mitogen-activated proteinkinase pathway is essential for the cytoprotective effect of CO in a variety of cell types (46) . Moreover, CO and CO-RMs decrease the production of proinflammatory cytokines, simultaneously increasing the expression of anti-inflammatory cytokines in innate immune cells (47) . Finally, CO binds to soluble guanylate cyclase indicating that activation of this enzyme and the increased production of its end product cGMP are responsible for the anti-inflammatory action of CO. The last hypothesis is supported by our previous data (40) and by the present research showing that the inhibition afforded by CORM-3 on intracellular calcium in neutrophils is abolished by blocking guanylate cyclase.
The present data recapitulate on previous reports demonstrating a potential therapeutic role for CO-RMs in the treatment of inflammatory-and cardiovascularrelated pathologies. These compounds were initially identified and characterized for their vascular activities (38, 48) but then shown to be protective against cardiac and renal dysfunctions (49, 50) . Because of the versatile nature of HO-1 as a ubiquitous and effective cytoprotective system, the application of the CO-RMs technology could be extended to a variety of disorders. For instance, a recent study reported that CORM-3 inhibits collagen and thrombin-induced aggregation of human platelets by a mechanism independent of soluble guanylate cyclase (51) . In BV-2 microglia cells, CORM-3 markedly attenuated the inflammatory response to thrombin and interferon gamma, suggesting that the use of CO carriers could be relevant for the treatment of stroke-related neuroinflammatory responses (52) .
In conclusion, CO liberated from CORM-3 exerts notable anti-inflammatory actions by down-regulating the inflammatory response of PMNs, ECs, and MCs. These effects, added to the vascular relaxation, the cytoprotection in ischemia-reperfusion, and the inhibition of platelet aggregation, render CORM-3 a suitable candidate as a therapeutic tool in cardiovascular diseases.
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